Perrigo Ordinary Shares reported $1.14B in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8869M 114M
Abbvie ABBV:US $ 11288M 2467M
Bayer BAYN:GR 12.65B 2.22B
Bristol Myers Squibb BMY:US $ 9.3B 202M
Catalent CTLT:US $ 1.06B 6M
Coherus Biosciences CHRS:US $ 104.16M 43.1M
Corcept Therapeutics CORT:US $ 71.95M 5.04M
Dr.Reddys Laboratories DRRD:IN 45.94B 7.23B
Eli Lilly And LLY:US $ 5277.9M 127.8M
Horizon Pharma HZNP:US $ 787.85M 96.93M
JAZZ PHA JAZZ:US $ 847.33M 121.16M
Johnson & Johnson JNJ:US $ 18.18B 616M
Lannett LCI:US $ 100.44M 54.15M
Merk MRK:US $ 9666M 666M
Pacira Pharmaceuticals PCRX:US $ 138.18M 2.42M
Perrigo Ordinary Shares PRGO:US $ 1137.9M 85.1M
Pfizer PFE:US $ 15640M 148M
Phibro Animal Health PAHC:US $ 220.42M 10.01M
Prestige Brands PBH:US $ 190.04M 534K
Supernus Pharmaceuticals SUPN:US $ 158.7M 8.17M
Teva Pharmaceutical TEVA:IT 4.74B 361M
Xeris Pharmaceuticals Inc XERS:US $ 44.22M 6.92M
Zoetis ZTS:US $ 1.38B 123M